Insmed | INSM - Interest Expense On Debt

Stock Price
157.16
Daily Change
3.18 2.07%
Monthly
-10.30%
Yearly
94.00%
Q1 Forecast
152.04

Insmed reported $20.38M in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
BioMarin Pharmaceutical USD 2.58M 100K Sep/2025
Cytokinetics USD 26.32M 2.06M Sep/2025
DBV Technologies USD 461K 323.71K Mar/2025
Dynavax Technologies USD 1.64M 2K Sep/2025
Gilead Sciences USD 254M 6M Jun/2025
Insmed USD 20.38M 863K Sep/2025
Novartis USD 281M 8M Sep/2025
Regeneron Pharmaceuticals USD 12.2M 7.1M Dec/2025
Sarepta Therapeutics USD 7.56M 2.33M Sep/2025
Ultragenyx Pharmaceutical USD 14.15M 108K Sep/2025
Vertex Pharmaceuticals USD 3.3M 400K Sep/2025